Add Company
Join Now

InstyMeds Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Tech Services

Industry

Estimated Revenue & Valuation

  • InstyMeds's estimated annual revenue is currently $4.9M per year.(i)
  • InstyMeds's estimated revenue per employee is $116,000

Employee Data

  • InstyMeds has 42 Employees.(i)
  • InstyMeds grew their employee count by 2% last year.

InstyMeds's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
CFOReveal Email/Phone
4
VP Sales & Account ManagementReveal Email/Phone
5
VP Pharmacy ServicesReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Distribution ManagerReveal Email/Phone
8
Mechanical Design EngineerReveal Email/Phone
9
Electrical Design EngineerReveal Email/Phone
10
Staff AccountantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.2M2210%N/AN/A
#2
$9.1M700%N/AN/A
#3
$27.8M1741%N/AN/A
#4
$1.2M140%N/AN/A
#5
$1M120%N/AN/A
#6
$1M1110%N/AN/A
#7
$0.1M2-78%N/AN/A
#8
$0.1M1-75%N/AN/A
#9
$2.9M29-12%N/AN/A
#10
$2.3M23-8%N/AN/A
Add Company

What Is InstyMeds?

The InstyMeds Prescription Medication Dispenser is the health care industry's only fully-automated, ATM-style dispenser of prescription medications that dispenses directly to patients at the point of care. State-of-the-art InstyMeds technology ensures safe and secure dispensing of prescription medications directly to patients at the point-of-care. InstyMeds mission is to Improve patient compliance and satisfaction by providing convenient prescription medication access to patients onsite of the hospital or clinic. Contact our National Dispensing Consultant to learn how InstyMeds can help your facility! Justin.Arseneau@InstyMeds.Com

keywords:N/A

N/A

Total Funding

42

Number of Employees

$4.9M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M425%N/A
#2
$5.5M435%N/A
#3
$6M438%N/A
#4
$9.5M445%N/A
#5
$3.5M457%N/A